EGLN1 and renal cell carcinoma: Positive nuclear expression of PHD2 was associated with a decreased risk of disease recurrence or death from RCC in univariable analysis and retained its association in multivariable analysis regardless of other relevant histopathological prognostic factors such as pT‐stage, nuclear grade, microvascular invasion, and histological tumor necrosis in both cohorts.